← Leaderboards
Erika J Crosby
Duke University
$396,200
Attributed
$396,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $161.5K · FY2022–24$200K$150K$100K$50K$0
'22
'23
'24
Funding mix
By agency
NIH$396,200 · 1
By mechanism
K22$396,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Sudarshan K Rajagopal$6,060,418
- Robert Matthew Tighe$4,987,592
- Zachary Conrad Hartman$2,643,521
- Dan Gabriel Duda$6,457,636
- Scott J Antonia$4,663,305
Others in their field
Other Rising Stars on “Anti-Pd-L1”
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$1,845,847
- Zhiguo Li · University Of Kentucky$1,749,738
- Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr$1,411,915
- Mark Yarchoan · Johns Hopkins University$1,293,190
- Balasubramanyam Karanam · Tuskegee University$1,091,867
- Esra Akbay · Ut Southwestern Medical Center$1,040,071
Research focus
Anti-Pd-L1ElectroporationAnti-Tumor Immune ResponseAntitumor ResponseDisorder ControlBiological MarkersBrca1 GeneBreast Cancer ModelBreast Cancer PatientBreast Cancer TreatmentAdaptive Immune ResponseCancer TypeCd8-Positive T-LymphocytesCellsChemokineClinical DataClinical ResearchCombination ImmunotherapyCrispr ScreenCxcl9 GeneCxcr3 GeneData SetDesignEngineering
Grant awards (3)
Intratumoral immunotherapy to enhance T cell infiltration and augment immune checkpoint blockade responses across molecular subtypes of breast cancer$117,141
K22 · FY2024 · CA · contact PI
Intratumoral immunotherapy to enhance T cell infiltration and augment immune checkpoint blockade responses across molecular subtypes of breast cancer$117,573
K22 · FY2023 · CA · contact PI
Intratumoral immunotherapy to enhance T cell infiltration and augment immune checkpoint blockade responses across molecular subtypes of breast cancer$161,486
K22 · FY2022 · CA · contact PI